• Change country/language

    Looks like you’re in {} — you’re on the {} site.

    Change Country
    Cancel

    Country and language selected

    You are being redirected to the {} site. Products and services availability vary by country. Do you wish to continue?

    Continue
    Cancel

Product

Product
Imaging
Bone & Metabolic Health Computed Tomography Fluoroscopy Interventional Guided Systems Magnetic Resonance Imaging Mammography Molecular Imaging Radiography (X-ray) Surgical Imaging All Imaging
Ultrasound
LOGIQ General Imaging Point of Care Versana Primary Care Vscan Air Handheld Vivid Cardiovascular Voluson Women's Health Verisound Ultrasound Digital Solutions All Ultrasound
Anaesthesia Delivery
Diagnostic Cardiology
Diagnostic ECG
Maternal & Infant Care
Patient Monitoring
Pharmaceutical Imaging Agents
Contrast Media Nuclear Imaging Agents
Healthcare IT
Advanced Visualization Hospital Operations | Command Center All Digital Solutions
Parts and Accessories
Clinical Accessories Imaging Accessories Service Shop

Services

Services
MyGEHealthcare Account
Healthcare Technology Management
Clinical Network Solutions
Service Shop

Support

Support
Education
Healthcare Learning System
Support and Documentation
Cleaner and Disinfectant Compatibility Disinfection of Ultrasound Probes Interoperability
Contact

Specialities

Specialities
Cardiology
Oncology

Insights

Insights
Insights Home
Docuseries
Thought Leadership
Podcasts

Shop

Shop
Vscan Handheld Ultrasound
Vscan Air CL Vscan Air SL
Service Shop
Accessories & Supplies
Shop All

About Us

About Us
Careers
About Us
Contact
Suppliers

    Relapses for DLBCL and HL patients occur early in the post-treatment course and remain eligible for curative therapies.5 CT, PET, and PET/CT are routinely used for patient monitoring.

    Products

    Card Image

    Q.Clear

    Do you know your patient’s response score? Q.Clear delivers quantitative SUV you and your patients can trust.

    Card Image

    PET/CT

    The true potential of PET/CT is its ability to enable a true discovery.

    References:
    5. Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma. Jonathon B. Cohen,1 Madhusmita Behera,1 Carrie A. Thompson,2 and Christopher R. Flowerscorresponding author1 Blood. 2017 Feb 2; 129(5): 561–564.
    JB04823XX